Medical University "Reaviz"

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Lung cancer2 trials
• Ulcerative colitis2 trials

Phase

• Phase 2/32 trials
• Phase 32 trials
• Phase 1/21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Mabscale, LLC1 trial
• Pfizer1 trial
• Shire1 trial

Running trials

• Recruiting

  A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

  NCT05654454· Phase 3· Mabscale, LLC· Source

  Contact: Kopp

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Completed

  Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

  NCT04181788· Phase 1/2· Pfizer· Source

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Shire· Source